Advertisement

Reflecting on Prevention Technologies

Chapter
  • 698 Downloads
Part of the SpringerBriefs in Public Health book series (BRIEFSPUBLIC)

Abstract

Advances in HIV prevention technologies such as the use of HIV treatments as prevention (TasP) offer new tools in the fight against AIDS. This chapter examines how biomedical devices have morphed into behavioral interventions over the past 30 years. Of particular interest are sterile syringes, condoms, and HIV antibody testing; medical technologies now thought of as behavioral interventions. These highly effective prevention tools have been stymied by politics, misguided policies, poor allocation of resources, and failure to invest in behavioral components to their use. These experiences offer important insights into how treatments could fail as prevention. The chapter concludes with recommendations for avoiding the pitfalls of past prevention technologies.

Keywords

Injection Drug User Female Condom Needle Exchange Male Condom Prevention Counseling 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 10.
    El-Bassel N, Jemmott JB, Landis JR, Pequegnat W, Wingood GM, Wyatt GE, et al. National Institute of Mental Health Multisite Eban HIV/STD Prevention Intervention for African American HIV Serodiscordant Couples: a cluster randomized trial. Arch Intern Med. 2010;170(17):1594–601. Epub 14 July 2010.PubMedCrossRefGoogle Scholar
  2. 21.
    Kamb M, Fishbein M, Douglas J, Rhodes F, Rogers J, Bolan G, et al. Efficacy of risk-reduction counseling to prevent Human Immunodeficiency Virus and Sexually Transmitted Diseases. J Am Med Assoc. 1998;280(13):1161–7.CrossRefGoogle Scholar
  3. 22.
    Investigators E. HIVNET 015 executive summary [protocol document available from the study team]. 2004; In press.Google Scholar
  4. 32.
    Rotheram-Borus MJ, Ingram BL, Swendeman D, Flannery D. Common principles embedded in effective adolescent HIV prevention programs. AIDS Behav. 2009;13(3):387–98. Epub 19 Feb 2009.PubMedCrossRefGoogle Scholar
  5. 52.
    McBride CM, Emmons KM, Lipkus IM. Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res. 2003;18(2):156–70. Epub 6 May 2003.PubMedCrossRefGoogle Scholar
  6. 57.
    Palmateer N, Kimber J, Hickman M, Hutchinson S, Rhodes T, Goldberg D. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Addiction. 2010;105(5):844–59. Epub 12 Mar 2010.PubMedCrossRefGoogle Scholar
  7. 58.
    Hyshka E, Strathdee S, Wood E, Kerr T. Needle exchange and the HIV epidemic in Vancouver: lessons learned from 15 years of research. Int J Drug Policy. 2012. Epub 15 May 2012.Google Scholar
  8. 59.
    Gillies M, Palmateer N, Hutchinson S, Ahmed S, Taylor A, Goldberg D. The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review. BMC Public Health. 2010;10:721. Epub 26 Nov 2010.PubMedCrossRefGoogle Scholar
  9. 60.
    Kalichman SC, Kelly JA, Sikkema KJ, Koslov AP, Shaboltas A, Granskaya J. The emerging AIDS crisis in Russia: review of enabling factors and prevention needs. Int J STD AIDS. 2000;11(2):71–5. Epub 4 Mar 2000.PubMedCrossRefGoogle Scholar
  10. 61.
    Tobin KE, Muessig KE, Latkin CA. HIV seropositive drug users’ attitudes towards partner notification (PCRS): results from the SHIELD study in Baltimore, Maryland. Patient Educ Couns. 2007;67(1–2):137–42. Epub 24 Apr 2007.PubMedCrossRefGoogle Scholar
  11. 62.
    Latkin CA, Sherman S, Knowlton A. HIV prevention among drug users: outcome of a network-oriented peer outreach intervention. Health Psychol. 2003;22(4):332–9. Epub 28 Aug 2003.PubMedCrossRefGoogle Scholar
  12. 63.
    Purcell DW, Metsch LR, Latka M, Santibanez S, Gomez CA, Eldred L, et al. Interventions for seropositive injectors-research and evaluation: an integrated behavioral intervention with HIV-positive injection drug users to address medical care, adherence, and risk reduction. J Acquir Immune Defic Syndr. 2004;37 Suppl 2:S110–8. Epub 24 Sept 2004.PubMedCrossRefGoogle Scholar
  13. 64.
    Knowlton AR, Hua W, Latkin C. Social support networks and medical service use among HIV-positive injection drug users: implications to intervention. AIDS Care. 2005;17(4):479–92. Epub 23 July 2005.PubMedCrossRefGoogle Scholar
  14. 65.
    Latkin CA, Donnell D, Metzger D, Sherman S, Aramrattna A, Davis-Vogel A, et al. The efficacy of a network intervention to reduce HIV risk behaviors among drug users and risk partners in Chiang Mai, Thailand and Philadelphia, USA. Soc Sci Med. 2009;68(4):740–8. Epub 17 Dec 2008.PubMedCrossRefGoogle Scholar
  15. 66.
    Tobin KE, Hua W, Costenbader EC, Latkin CA. The association between change in social network characteristics and non-fatal overdose: results from the SHIELD study in Baltimore, MD, USA. Drug Alcohol Depend. 2007;87(1):63–8. Epub 12 Sept 2006.PubMedCrossRefGoogle Scholar
  16. 67.
    Latkin CA, Davey MA, Hua W. Social context of needle selling in Baltimore, Maryland. Subst Use Misuse. 2006;41(6–7):901–13. Epub 1 July 2006.PubMedCrossRefGoogle Scholar
  17. 68.
    Friedman SR, Bolyard M, Mateu-Gelabert P, Goltzman P, Pawlowicz MP, Singh DZ, et al. Some data-driven reflections on priorities in AIDS network research. AIDS Behav. 2007;11(5):641–51. Epub 21 Oct 2006.PubMedCrossRefGoogle Scholar
  18. 69.
    Friedman SR, Mateu-Gelabert P, Curtis R, Maslow C, Bolyard M, Sandoval M, et al. Social capital or networks, negotiations, and norms? A neighborhood case study. Am J Prev Med. 2007;32(6 Suppl):S160–70. Epub 19 Aug 2007.PubMedCrossRefGoogle Scholar
  19. 70.
    Kost K, Singh S, Vaughan B, Trussell J, Bankole A. Estimates of contraceptive failure from the 2002 National Survey of Family Growth. Contraception. 2008;77(1):10–21. Epub 18 Dec 2007.PubMedCrossRefGoogle Scholar
  20. 71.
    Crosby RA, Diclemente RJ, Wingood GM, Salazar LF, Rose E, Levine D, et al. Correlates of condom failure among adolescent males: an exploratory study. Prev Med. 2005;41(5–6):873–6. Epub 1 Nov 2005.PubMedCrossRefGoogle Scholar
  21. 72.
    Kalichman SC, Simbayi LC, Cain D, Jooste S. Condom failure among men receiving sexually transmissible infection clinic services, Cape Town, South Africa. Sex Health. 2009;6(4):300–4. Epub 18 Nov 2009.PubMedCrossRefGoogle Scholar
  22. 73.
    Chow EP, Wilson DP, Zhang L. Patterns of condom use among men who have sex with men in China: a systematic review and meta-analysis. AIDS Behav. 2012;16(3):653–63. Epub 5 Apr 2011.PubMedCrossRefGoogle Scholar
  23. 74.
    Kelly JA, Kalichman SC. Increased attention to human sexuality can improve HIV-AIDS prevention efforts: key research issues and directions. J Consult Clin Psychol. 1995;63(6):907–18. Epub 1 Dec 1995.PubMedCrossRefGoogle Scholar
  24. 75.
    Koop CE. The early days of AIDS, as I remember them. Ann Forum Collab HIV Res. 2011;13:5–10.Google Scholar
  25. 76.
    Trenholm C, Devaney B, Fortson K, Clark M, Bridgespan LQ, Wheeler J. Impacts of abstinence education on teen sexual activity, risk of pregnancy, and risk of sexually transmitted diseases. J Policy Anal Manage. 2008;27(2):255–76. Epub 12 Apr 2008.PubMedCrossRefGoogle Scholar
  26. 77.
    Jemmott 3rd JB, Jemmott LS, Fong GT. Abstinence and safer sex HIV risk-reduction interventions for African American adolescents: a randomized controlled trial. JAMA. 1998;279(19):1529–36. Epub 30 May 1998.PubMedCrossRefGoogle Scholar
  27. 78.
    Barnett T, Parkhurst J. HIV/AIDS: sex, abstinence, and behaviour change. Lancet Infect Dis. 2005;5(9):590–3. Epub 27 Aug 2005.PubMedCrossRefGoogle Scholar
  28. 79.
    Lyles CM, Kay LS, Crepaz N, Herbst JH, Passin WF, Kim AS, et al. Best-evidence interventions: findings from a systematic review of HIV behavioral interventions for US populations at high risk, 2000-2004. Am J Public Health. 2007;97(1):133–43. Epub 2 Dec 2006.PubMedCrossRefGoogle Scholar
  29. 80.
    Nelson KE, Celentano DD, Eiumtrakol S, Hoover DR, Beyrer C, Suprasert S, et al. Changes in sexual behavior and a decline in HIV infection among young men in Thailand. N Engl J Med. 1996;335(5):297–303. Epub 1 Aug 1996.PubMedCrossRefGoogle Scholar
  30. 81.
    Rojanapithayakorn W, Hanenberg R. The 100% condom program in Thailand. AIDS. 1996;10(1):1–7. Epub 1 Jan 1996.PubMedCrossRefGoogle Scholar
  31. 82.
    Merson M. International perspective on AIDS prevention research in NIH consensus development conference on interventions to prevent HIV risk behaviors In: Health NIo, editor. Bethesda, MD; 1997.Google Scholar
  32. 83.
    Wingood GM, DiClemente RJ, Mikhail I, Lang DL, McCree DH, Davies SL, et al. A randomized controlled trial to reduce HIV transmission risk behaviors and sexually transmitted diseases among women living with HIV: The WiLLOW Program. J Acquir Immune Defic Syndr. 2004;37 Suppl 2:S58–67. Epub 24 Sept 2004.PubMedCrossRefGoogle Scholar
  33. 84.
    Sandoy IF, Zyaambo C, Michelo C, Fylkesnes K. Targeting condom distribution at high risk places increases condom utilization-evidence from an intervention study in Livingstone, Zambia. BMC Public Health. 2012;12:10. Epub 10 Jan 2012.PubMedCrossRefGoogle Scholar
  34. 85.
    Kenya: Female Condom Shortage. Humanitarian news and analysis. 2009.Google Scholar
  35. 86.
    Cecil H, Pinkerton SD, Bogart LM. Perceived benefits and barriers associated with the female condom among African-American adults. J Health Psychol. 1999;4(2):165–75. Epub 1 Mar 1999.PubMedCrossRefGoogle Scholar
  36. 87.
    Gallo MF, Kilbourne-Brook M, Coffey PS. A review of the effectiveness and acceptability of the female condom for dual protection. Sex Health. 2012;9(1):18–26. Epub 22 Feb 2012.PubMedCrossRefGoogle Scholar
  37. 88.
    Beksinska ME, Smit JA, Mantell JE. Progress and challenges to male and female condom use in South Africa. Sex Health. 2012;9(1):51–8. Epub 22 Feb 2012.PubMedCrossRefGoogle Scholar
  38. 89.
    Kelvin EA, Mantell JE, Candelario N, Hoffman S, Exner TM, Stackhouse W, et al. Off-label use of the female condom for anal intercourse among men in New York City. Am J Public Health. 2011;101(12):2241–4. Epub 25 Oct 2011.PubMedCrossRefGoogle Scholar
  39. 90.
    Kalichman SC, Rompa D, Cage M. Factors associated with female condom use among HIV-seropositive women. Int J STD AIDS. 2000;11(12):798–803. Epub 4 Jan 2001.PubMedCrossRefGoogle Scholar
  40. 91.
    Marseille E, Kahn JG. Smarter programming of the female condom: increasing its impact on HIV prevention in the developing world. 2008Google Scholar
  41. 92.
    Kalichman SC, Williams E, Nachimson D. Brief behavioural skills building intervention for female controlled methods of STD-HIV prevention: outcomes of a randomized clinical field trial. Int J STD AIDS. 1999;10(3):174–81. Epub 26 May 1999.PubMedCrossRefGoogle Scholar
  42. 93.
    Hoke TH, Feldblum PJ, Damme KV, Nasution MD, Grey TW, Wong EL, et al. Randomised controlled trial of alternative male and female condom promotion strategies targeting sex workers in Madagascar. Sex Transm Infect. 2007;83(6):448–53. Epub 27 June 2007.PubMedCrossRefGoogle Scholar
  43. 94.
    Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006;20(10):1447–50. Epub 23 June 2006.PubMedCrossRefGoogle Scholar
  44. 95.
    Phillips KA, Bayer R, Chen JL. New Centers for Disease Control and Prevention’s guidelines on HIV counseling and testing for the general population and pregnant women. J Acquir Immune Defic Syndr. 2003;32(2):182–91. Epub 7 Feb 2003.PubMedCrossRefGoogle Scholar
  45. 96.
    Holtgrave D, McGuire J. Impact of counseling in voluntary counseling and testing programs for persons at risk for or living with HIV infection. Clin Infect Dis. 2007;45 Suppl 4:S240–3. Epub 8 Feb 2008.PubMedCrossRefGoogle Scholar
  46. 97.
    Estrada BD, Trujillo S, Estrada AL. Supporting Healthy Alternatives through Patient Education: a theoretically driven HIV prevention intervention for persons living with HIV/AIDS. AIDS Behav. 2007;11(5 Suppl):S95–105. Epub 1 Feb 2007.PubMedCrossRefGoogle Scholar
  47. 98.
    Metcalf CA, Malotte CK, Douglas Jr JM, Paul SM, Dillon BA, Cross H, et al. Efficacy of a booster counseling session 6 months after HIV testing and counseling: a randomized, controlled trial (RESPECT-2). Sex Transm Dis. 2005;32(2):123–9. Epub 26 Jan 2005.PubMedCrossRefGoogle Scholar
  48. 99.
    Cohen MS, Shaw GM, McMichael AJ, Haynes BF. Acute HIV-1 infection. N Engl J Med. 2011;364(20):1943–54. Epub 20 May 2011.PubMedCrossRefGoogle Scholar
  49. 100.
    Hightow-Weidman LB, Golin CE, Green K, Shaw EN, MacDonald PD, Leone PA. Identifying people with acute HIV infection: demographic features, risk factors, and use of health care among individuals with AHI in North Carolina. AIDS Behav. 2009;13(6):1075–83. Epub 8 Jan 2009.PubMedCrossRefGoogle Scholar
  50. 101.
    Kelly JA, St Lawrence JS, Diaz YE, Stevenson LY, Hauth AC, Brasfield TL, et al. HIV risk behavior reduction following intervention with key opinion leaders of population: an experimental analysis. Am J Public Health. 1991;81(2):168–71. Epub 1 Feb 1991.PubMedCrossRefGoogle Scholar
  51. 102.
    Kelly JA, St Lawrence JS, Stevenson LY, Hauth AC, Kalichman SC, Diaz YE, et al. Community AIDS/HIV risk reduction: the effects of endorsements by popular people in three cities. Am J Public Health. 1992;82(11):1483–9 Epub 1 Nov 1992.PubMedCrossRefGoogle Scholar
  52. 103.
    Kelly JA, Murphy DA, Sikkema KJ, McAuliffe TL, Roffman RA, Solomon LJ, et al. Randomised, controlled, community-level HIV-prevention intervention for sexual-risk behaviour among homosexual men in US cities. Community HIV Prevention Research Collaborative. Lancet. 1997;350(9090):1500–5. Epub 6 Dec 1997.PubMedCrossRefGoogle Scholar
  53. 104.
    Morin SF. AIDS: the challenge to psychology. Am Psychol. 1988;43(11):838–42. Epub 1 Nov 1988.PubMedCrossRefGoogle Scholar
  54. 104.
    Morin SF. AIDS: the challenge to psychology. Am Psychol. 1988;43(11):838–42. Epub 1 Nov 1988.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Center for HIV Intervention and PreventionUniversity of ConnecticutStorrsUSA

Personalised recommendations